Abemaciclib and Exemestane: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Clinical studies found no clinically relevant pharmacokinetic interaction with these endocrine treatment partners.
Clinical significance and safety
Abemaciclib and Exemestane may be used together as part of an appropriate breast-cancer regimen selected by the oncology team. The absence of a clinically relevant pharmacokinetic interaction does not remove each medicine’s safety precautions. Continue the prescribed monitoring, including assessment of clotting risk where relevant, and do not start or stop a cancer-treatment combination yourself.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.